A U.S. government agency has threatened Johnson & Johnson with sanctions if the company proceeds with plans to alter payment methods for some hospitals that participate in a federal drug discount ...

States continue to notch victories in legal battles with pharmaceutical manufacturers over the use of contract pharmacies to dispense 340B drugs, potentially setting up a Supreme Court showdown.

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to ...

Sen. Peter Welch (D-Vt.) has introduced a bill that would ban pharmaceutical companies from restricting access to 340B drug pricing program discounts, according to a Sept. 11 press release shared ...

The Health Resources and Services Administration (HRSA) has told Johnson & Johnson to "immediately" end its plan to provide required 340B drug discounts after the fact via rebate. J&J had proposed ...

6. U.S. District Judge Matthew Maddox issued a preliminary order on Sept. 5 blocking program 340B, according to court documents obtained by Becker's. The judge's written order did not explain his ...

Drugmakers and providers are perennially at odds over 340B, which was enacted three decades ago to ensure hospitals serving a large number of low-income or otherwise needy patients could afford ...

Currently, the eligible providers get the 340B discounts at the time of purchase. The drugmaker outlined the policy in a notice issued on Aug. 23, stipulating that the tweaks would take effect on ...

In an Aug. 23 notice, J&J said terms will change for hospitals that buy the drugs — the Xarelto blood thinner and the Stelara plaque psoriasis treatment — through the 340B drug discount program.

Starting October 15, Johnson & Johnson will stop providing upfront discounts to disproportionate share hospitals (DSH) participating in the 340B Drug Pricing Program for the plaque psoriasis drug ...

Coveraged hospitals in the 340B Drug Pricing Program must buy these drugs at full price and submit data to Johnson & Johnson Once the drug's 340B status is verified, the hospitals will receive a ...